Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Travere Therapeutics, Inc. (TVTX) had Current Ratio of 2.74 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$129.69M |
|
$2.73M |
|
$2.55M |
|
$127.13M |
|
$162.12M |
|
$-32.43M |
|
$11.37M |
|
$-21.07M |
|
$-21.07M |
|
$-21.99M |
|
$-21.99M |
|
$2.73M |
|
$-21.99M |
|
$-32.43M |
|
$-17.09M |
|
89.21M |
|
89.21M |
|
$0.03 |
|
$0.04 |
|
| Balance Sheet Financials | |
$437.56M |
|
$4.02M |
|
$167.63M |
|
$605.19M |
|
$159.90M |
|
$311.72M |
|
$330.46M |
|
$490.36M |
|
$114.83M |
|
$0.96M |
|
$114.83M |
|
90.92M |
|
| Cash Flow Statement Financials | |
$37.78M |
|
$27.89M |
|
$-33.47M |
|
$58.53M |
|
$93.03M |
|
$34.50M |
|
$44.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
2.74 |
-- |
|
-- |
|
0.73 |
|
2.71 |
|
98.03% |
|
-25.01% |
|
-25.01% |
|
-- |
|
-16.24% |
|
2.10% |
|
$37.78M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.43 |
|
1.62 |
|
55.61 |
|
-19.15% |
|
-2290.26% |
|
-3.63% |
|
-5.15% |
|
$1.26 |
|
$0.42 |
|
$0.42 |
|